In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan

Antimicrob Agents Chemother. 2008 Jul;52(7):2677-9. doi: 10.1128/AAC.00002-08. Epub 2008 May 12.

Abstract

All 198 Salmonella isolates (58.6% of isolates were resistant to tetracycline), 92 Vibrio isolates (4.4% of isolates were resistant to tetracycline), and 200 of 201 Aeromonas isolates (39.3% of isolates were resistant to tetracycline; 1 A. caviae isolate had a tigecycline MIC of 4 mug/ml) in our study were susceptible to tigecycline, by U. S. Food and Drug Administration criteria for Enterobacteriaceae.

MeSH terms

  • Aeromonas / drug effects*
  • Aeromonas / isolation & purification
  • Anti-Bacterial Agents / pharmacology*
  • Gram-Negative Bacterial Infections / drug therapy
  • Gram-Negative Bacterial Infections / microbiology
  • Humans
  • In Vitro Techniques
  • Microbial Sensitivity Tests
  • Minocycline / analogs & derivatives*
  • Minocycline / pharmacology
  • Salmonella / drug effects*
  • Salmonella / isolation & purification
  • Salmonella Infections / drug therapy
  • Salmonella Infections / microbiology
  • Taiwan
  • Tetracycline Resistance
  • Tigecycline
  • Vibrio / drug effects*
  • Vibrio / isolation & purification
  • Vibrio Infections / drug therapy
  • Vibrio Infections / microbiology

Substances

  • Anti-Bacterial Agents
  • Tigecycline
  • Minocycline